Intrinsiqs

Is Pelthos Therapeutics Inc. overvalued?

Pelthos Therapeutics Inc. (PTHS) — key valuation metrics and fundamentals.

No verdict
Price
$7.44
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$29.3M
Dividend yield
0.0%
Return on equity
-381.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PTHS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.